Previous close | 30.45 |
Open | 30.50 |
Bid | 30.36 x 300 |
Ask | 30.42 x 300 |
Day's range | 30.30 - 30.80 |
52-week range | 25.92 - 36.74 |
Volume | |
Avg. volume | 2,682,937 |
Market cap | 18.144B |
Beta (5Y monthly) | 0.45 |
PE ratio (TTM) | 12.00 |
EPS (TTM) | 2.53 |
Earnings date | 07 May 2024 - 13 May 2024 |
Forward dividend & yield | 0.84 (2.76%) |
Ex-dividend date | 15 Feb 2024 |
1y target est | 45.50 |
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen’s 44th Annual Health Care Conference on March 5, 2024 at 10:30 a.m. ET. The webcast will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/events/. The webcast will also be archived for a minimum of thirty days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical
It's been a good week for Royalty Pharma plc ( NASDAQ:RPRX ) shareholders, because the company has just released its...
Royalty Pharma ( NASDAQ:RPRX ) Full Year 2023 Results Key Financial Results Revenue: US$2.35b (up 5.2% from FY 2022...